ストックスクリーナーアプリを入手
0.00
100.00%
-4.26
前日終値:
$4.26
開ける：
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額：
$364.61M
収益：
$103.00K
当期純損益:
$-42.47M
株価収益率:
0.00
EPS:
-1.9
ネットキャッシュフロー:
$-34.30M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
$0.00
$0.00
1週間の範囲:
$0.00
$0.00
52週間の値動き範囲:
$0.00
$4.50
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
名前
Checkpoint Therapeutics Inc
セクター
電話
781-652-4500
住所
95 SAWYER ROAD, WALTHAM, NY
CKPT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CKPT
Checkpoint Therapeutics Inc
|
0.00 | 364.61M | 103.00K | -42.47M | -34.30M | -1.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.36 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.75 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.50 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
538.64 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.47 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-13 | 開始されました | D. Boral Capital | Buy |
| 2022-07-14 | 再開されました | B. Riley Securities | Buy |
| 2021-06-09 | 開始されました | B. Riley Securities | Buy |
| 2021-01-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-05-29 | 開始されました | Lake Street | Buy |
| 2017-12-08 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Checkpoint Therapeutics Inc (CKPT) 最新ニュース
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Shares Bought by Bank of America Corp DE - Defense World
54,186 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Acquired by Millennium Management LLC - Defense World
Two Sigma Investments LP Grows Stock Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Squarepoint Ops LLC Purchases Shares of 71,938 Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Wealth Enhancement Advisory Services LLC Has $1.36 Million Stock Position in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Northern Trust Corp Purchases 10,232 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics, Inc.(NasdaqCM: CKPT) dropped from S&P TMI Index - marketscreener.com
Checkpoint Therapeutics Completes Merger with Sun Pharma Subsidiary - MSN
Sun Pharma concludes acquisition of Checkpoint Therapeutics - Medical Dialogues
Sun Pharma Finalizes $416M Deal for Checkpoint Therapeutics, Inc. (CKPT) - Insider Monkey
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpo - GuruFocus
Checkpoint Therapeutics finalizes acquisition by Sun Pharma - Investing.com Nigeria
Sun Pharma Completes its Acquisition of Checkpoint Therapeutics - citybiz
Sun Pharma completes its acquisition of Checkpoint Therapeutics - Moneycontrol
Fortress Biotech Announces Sale of Subsidiary Checkpoint Therapeutics - citybiz
Sun Pharmaceutical Industries Completes Acquisition Of Checkpoint Therapeutics - marketscreener.com
Fortress Biotech Closes Sale of Checkpoint Therapeutics Unit - marketscreener.com
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - The Manila Times
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics | FBIO Stock News - GuruFocus
Fortress Biotech, Inc. Announces Acquisition of Checkpoint Therapeutics by Sun Pharmaceutical Industries Limited - Nasdaq
Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics - Benzinga
Fortress Biotech Cashes In: $28M Upfront Plus Royalties in Strategic Checkpoint Sale to Sun Pharma - Stock Titan
Checkpoint Therapeutics finalizes acquisition by Sun Pharma By Investing.com - Investing.com South Africa
Checkpoint Therapeutics shareholders approve Sun Pharma merger By Investing.com - Investing.com India
Checkpoint Therapeutics shareholders approve Sun Pharma merger - Investing.com
Checkpoint Therapeutics Approves Merger with Sun Pharma - TipRanks
D. E. Shaw & Co. Inc. Has $95,000 Position in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics, Inc. (CKPT) Stock Analysis: Is There More Room to Grow Beyond Its 2.44% Potential Upside? - DirectorsTalk Interviews
Checkpoint Pharma Sued Over Controversial $355M Merger - USA Herald
Checkpoint Investor Sues for Info on Sale From Fortress to Sun - Bloomberg Law News
Checkpoint Therapeutics Reports Q1 2025 Financials and Updates - TipRanks
Checkpoint Therapeutics Announces Merger Progress By Investing.com - Investing.com Canada
Checkpoint Therapeutics Announces Merger Progress - Investing.com
Checkpoint Therapeutics Merger Awaits Stockholder Vote - TipRanks
Cancer Drug Co. Beats Investor Suit Over FDA Rejection - Law360
Checkpoint Therapeutics Beats Investor Suit Over FDA Assent (1) - Bloomberg Law News
Balyasny Asset Management L.P. Buys New Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Stifel Financial Corp Acquires New Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Earnings: Triple Win with $28M Checkpoint Deal, FDA Fast-Track, and Rosacea Drug Launch - Stock Titan
Lake Street Keeps Their Hold Rating on Checkpoint Therapeutics (CKPT) - The Globe and Mail
Tower Research Capital LLC TRC Acquires 6,486 Shares of Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics Reports First Quarter Financial Results and Recent Corporate Updates - GlobeNewswire
Checkpoint Therapeutics Secures $416M Merger Deal After Landmark FDA Cancer Drug Approval - Stock Titan
Envestnet Asset Management Inc. Has $214,000 Holdings in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Tecsys Placed as a Challenger in 2025 Gartner® Magic Quadrant™ for Warehouse Management Systems - The Globe and Mail
Marshall Wace LLP Decreases Stake in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) - Defense World
Checkpoint Therapeutics (CKPT) Expected to Announce Earnings on Friday - Defense World
Microsoft’s Stock Rises 9% As Financial Results Top Estimates - The Globe and Mail
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - marketscreener.com
Checkpoint Therapeutics Inc (CKPT) 財務データ
収益
当期純利益
現金流量
EPS
3.56%
0.22%
大文字化:
|
ボリューム (24 時間):